Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Breast Cancer|Prostate Cancer|Tumors (Others)|Ovarian Cancer
Interventions: BIOLOGICAL: MVA-brachyury- TRICOM
Sponsor: National Cancer Institute (NCI)